Indocyanine Green Angiography-Guided Assessment and Laser Photocoagulation for Diabetic Macular Edema: a pilot study

Indocyanine Green Angiography-Guided Assessment and Laser Photocoagulation for Diabetic Macular Edema: a pilot study - ICG-guided Laser Photocoagulation for Diabetic Macular Edema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012751

Enrollment

Registered

2014-01-06

Start date

2009-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Macular Edema

Interventions

Laser photocoagulation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with diffuse DME diagnosed on FA and a baseline best-corrected visual acuity (BCVA) of 20/400 to 20/30 were enrolled.

Exclusion criteria

Exclusion criteria: Eyes, which underwent scattered (panretinal) laser photocoagulation within 6 months prior to enrollment and which had hazy media because of corneal opacity, moderate to severe cataract, or dense vitreous hemorrhage, interfering with laser photocoagulation; and patients, who had any possible histories of allergic reaction to fluorescein dye, indocyanine green dye, or both.

Design outcomes

Primary

Measure	Time frame
Best corrected visual acuity and central retinal thickness and macular volume measured by optical coherence tomography	—

Countries

Japan

Contacts

Public ContactTsutomu Yasukawa

Nagoya City University Graduate School of Medical Sciences Ophthalmology and Visual Science

yasukawa@med.nagoya-cu.ac.jp+81-52-8538251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026